Definitive Contract 75N92020C00033
Award Date 9/29/20
Potential Completion Date 4/30/21
Potential Value $1.5M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New Zealand
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. National Institute of Biomedical Imaging and Bioengineering, part of the Department of Health and Human Services, awarded a $16,239,965.00 firm fixed price contract to Mologic Inc., a foreign-owned for-profit organization, for the Rapid Acceleration of Diagnostics (RADx) Program Tech Project #7697: SARS-CoV-2 Antigen Home Test. This contract, which does not have a set-aside designation, aims to deliver the testing products through January 2025 from Mologic's facility in Bedford, New...
- The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded Ellume USA LLC, a foreign-owned, self-certified small disadvantaged business, a $26,900,000 firm-fixed-price contract for the development of a point-of-care COVID-19 antigen test for the direct detection of the SARS-CoV-2 virus. This contract, part of the RADX-TECH program, has a completion date of March 29, 2023 and does not have a set-aside designation....
- This is a $309,084.78 firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Altratech LIMITED, a for-profit limited liability company based in Ireland. The contract is for research and development of an at-home saliva-based SARS-CoV-2 RNA detection kit with variant identification and wireless upload capabilities, under the Division of Research, Innovation, and Ventures' Area of Interest #11B: Enabling...
- The National Institutes of Health (NIH) awarded a $92,645,361.50 firm-fixed-price contract to Quidel Corporation to provide rapid COVID-19 antigen test kits under the Rapid Acceleration of Diagnostics (RADx) initiative. The contract, which does not have a set-aside designation, runs through April 30, 2025 and requires Quidel to deliver the tests from its facilities in San Diego, California. Quidel is a manufacturer of medical diagnostics and supplies, and has received numerous federal...
- Princeton Biomeditech Corp was awarded a definitive, firm fixed price contract valued at $10,062,372.12 by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for RADX TECH II PROJECTS 13356 & 13464, which involves developing and delivering a rapid, point-of-care multiplex assay and reader to simultaneously detect COVID-19 and influenza A & B antigens. Work will be performed in Monmouth Junction, New...
- The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm-fixed-price contract to Vela Diagnostics USA Inc. for the research and development of a probe-based reverse transcriptase polymerase chain reaction (RT-PCR) test for COVID-19. The contract, which was not set aside, has a potential value of $224,780 and a completion date of October 31, 2020. Vela Diagnostics USA Inc. is a global provider of integrated molecular...
- The Broad Institute, Inc., doing business as the Broad Institute of MIT and Harvard, has been awarded a definitive contract valued at $25.7 million by the National Institutes of Health's National Heart, Lung and Blood Institute to scale the Broad Institute's reverse transcription polymerase chain reaction (RT-PCR) process to support testing of over 100,000 samples per day. This contract is part of the Rapid Acceleration of Diagnostics (RADx) Advanced Technology Platforms program, which aims to...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $618,725 firm fixed price purchase order to Life Technologies Corporation for TAQPATH RTPCR COVID-19 test kits. The contract supports the agency's response to the Coronavirus national emergency and will provide testing supplies through January 2030. As the prime, Life Technologies will deliver their COVID-19 diagnostic products to meet testing requirements in Grand Island, New York. The award was made noncompetitively using...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $14.9 million firm fixed price definitive contract to ADL Diagnostics Inc., doing business as Harmony Diagnostics, to support the development and delivery of a low-cost, moderate-throughput COVID-19 test to enable massive testing scale-up at small clinics and community sites. Performance will take place in Woodinville, Washington through May 2023. The award responds to...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $19.3 million firm fixed price definitive contract to ANP Technologies Inc. to support the RADX TECH PROJECT #2620 for accelerated manufacturing scale-up of ANP Technologies' nano-intelligent detection system for COVID-19 antigen rapid testing. Performance will take place in Newark, Delaware over a two year period concluding in December 2022. No set aside designation or...